Xiaolong Wei Selected Research

Xiaolong Wei Research Topics

Disease

19	Neoplasms (Cancer) 05/2024 - 02/2007
8	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2006
3	Lung Neoplasms (Lung Cancer) 04/2024 - 01/2022
3	Liver Cirrhosis (Hepatic Cirrhosis) 06/2018 - 05/2013
2	Atherosclerosis 12/2023 - 07/2016
2	Aortic Dissection 01/2021 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2011
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2019 - 07/2016
2	Colorectal Neoplasms (Colorectal Cancer) 12/2017 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 02/2012 - 11/2010
1	Infections 05/2024
1	Chronic Obstructive Pulmonary Disease (COPD) 02/2024
1	Stroke (Strokes) 02/2024
1	Hematologic Neoplasms (Hematological Malignancy) 01/2024
1	Cognitive Dysfunction 05/2023
1	Esophageal Squamous Cell Carcinoma 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Laminopathies 11/2022
1	Fatty Liver 11/2022
1	Non-alcoholic Fatty Liver Disease 11/2022
1	Endoleak 04/2022
1	Metabolic Diseases (Metabolic Disease) 11/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Abdominal Aortic Aneurysm 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2020
1	Hypesthesia (Numbness) 01/2020
1	Pathologic Processes 01/2019
1	Carotid Artery Diseases 01/2019
1	Fibrosis (Cirrhosis) 06/2018
1	Thrombosis (Thrombus) 01/2018
1	Hypoxia (Hypoxemia) 11/2017
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Aneurysm (Aneurysms) 01/2017
1	Papillary Thyroid Cancer 12/2016
1	Papillary Carcinoma 12/2016
1	Hyperlipidemias (Hyperlipidemia) 07/2016
1	Pathologic Constriction (Stenosis) 07/2016

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2021
6	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2006
6	Messenger RNA (mRNA)IBA 01/2022 - 12/2016
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 04/2014
3	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 06/2018 - 05/2013
3	Anti-Mullerian HormoneIBA 02/2012 - 11/2010
2	Hematoxylin (Haematoxylon)IBA 01/2024 - 03/2014
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2024 - 03/2014
2	ChromatinIBA 11/2022 - 11/2018
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 01/2013
2	Estrogen ReceptorsIBA 11/2018 - 11/2014
2	Therapeutic UsesIBA 06/2018 - 03/2014
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018 - 07/2016
2	Epithelial Cell Adhesion MoleculeIBA 02/2012 - 11/2010
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2024
1	Immune Checkpoint InhibitorsIBA 05/2024
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2024
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 02/2024
1	Chimeric Antigen ReceptorsIBA 01/2024
1	Monoclonal AntibodiesIBA 12/2023
1	Lamin Type B (Lamin B)IBA 06/2023
1	2,2',4,4',5-pentachlorodiphenyl etherIBA 05/2023
1	COVID-19 VaccinesIBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	VaccinesIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	LipidsIBA 11/2022
1	IntegrinsIBA 10/2022
1	Glycogen Synthase (Synthase I)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2021
1	LigandsIBA 11/2021
1	Liver X ReceptorsIBA 11/2021
1	Aurora Kinase BIBA 01/2021
1	Untranslated RNA (Noncoding RNA)IBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Drug CombinationsIBA 11/2020
1	Gemcitabine FDA Link 11/2020
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	triphosphoric acid (triphosphate)IBA 01/2019
1	CarbonIBA 06/2018
1	CollagenIBA 06/2018
1	Sirtuin 1IBA 12/2016
1	oxidized low density lipoproteinIBA 07/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 07/2016
1	Lipoproteins (Lipoprotein)IBA 07/2016
1	Epoxide HydrolasesIBA 11/2014
1	Cytochrome P-450 CYP2J2 (CYP2J2)IBA 11/2014
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2014

Therapy/Procedure

3	Carotid Endarterectomy 02/2024 - 07/2016
2	Therapeutics 02/2024 - 10/2022
2	Length of Stay 02/2024 - 01/2023
2	Radiotherapy 10/2022 - 01/2021
2	Stents 04/2022 - 01/2017
2	Transplantation 06/2018 - 05/2013
1	Neoadjuvant Therapy 01/2024
1	Chemoradiotherapy 01/2021
1	Blood Transfusion (Blood Transfusions) 01/2020
1	Adjuvant Chemotherapy 03/2015